STAT3 and neoplasm: MiR-21 acts as an oncomiR by engaging PI3K/AKT and STAT3 signaling, miR-145 exerts tumor-suppressive effects by constraining migration and epithelial–mesenchymal transition, while miR-106a influences cell growth, apoptosis, and autophagy [28,29,30].